INVIVO THERAPEUTICS HOLDINGS CORP.: 10-Q filed 2011-08-10
What INVIVO THERAPEUTICS HOLDINGS CORP. reported in its quarterly report filed 2011-08-10 (fiscal Q2 2011): 25 published measures, 80 facts as tagged in accession 0001193125-11-218235.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2011-08-10
- Fiscal period
- fiscal Q2 2011
- Accession
- 0001193125-11-218235 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All INVIVO THERAPEUTICS HOLDINGS CORP. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 5,971,439 | USD | |
| At 2010-12-31 | 9,379,180 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 9,894,427 | USD | |
| At 2010-12-31 | 11,231,682 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | -3,922,988 | USD | |
| At 2010-12-31 | -1,852,502 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 4,963,947 | USD | |
| At 2010-12-31 | 8,964,194 | USD | |
| At 2010-06-30 | 197,758 | USD | |
| At 2009-12-31 | 226,667 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-06-30 | -1,370,138 | USD | 91 |
| 2011-01-01 to 2011-06-30 | -2,648,128 | USD | 181 |
| 2005-11-28 to 2011-06-30 | -15,736,727 | USD | 2041 |
| 2010-04-01 to 2010-06-30 | -970,445 | USD | 91 |
| 2010-01-01 to 2010-06-30 | -1,424,433 | USD | 181 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-06-30 | -3,778,282 | USD | 181 |
| 2005-11-28 to 2011-06-30 | -10,566,590 | USD | 2041 |
| 2010-01-01 to 2010-06-30 | -1,119,271 | USD | 181 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-06-30 | 211,503 | USD | 181 |
| 2005-11-28 to 2011-06-30 | 563,288 | USD | 2041 |
| 2010-01-01 to 2010-06-30 | 18,653 | USD | 181 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-06-30 | -10,462 | USD | 181 |
| 2005-11-28 to 2011-06-30 | 16,093,825 | USD | 2041 |
| 2010-01-01 to 2010-06-30 | 1,109,015 | USD | 181 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-06-30 | -211,503 | USD | 181 |
| 2005-11-28 to 2011-06-30 | -563,288 | USD | 2041 |
| 2010-01-01 to 2010-06-30 | -18,653 | USD | 181 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 525,940 | USD | |
| At 2010-12-31 | 280,181 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-06-30 | 510,342 | USD | 181 |
| 2005-11-28 to 2011-06-30 | 1,389,182 | USD | 2041 |
| 2010-01-01 to 2010-06-30 | 253,533 | USD | 181 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-06-30 | -2,527,341 | USD | 91 |
| 2011-01-01 to 2011-06-30 | -3,927,983 | USD | 181 |
| 2005-11-28 to 2011-06-30 | -12,404,635 | USD | 2041 |
| 2010-04-01 to 2010-06-30 | -794,271 | USD | 91 |
| 2010-01-01 to 2010-06-30 | -1,176,325 | USD | 181 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 5,310,143 | USD | |
| At 2010-12-31 | 9,045,360 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-06-30 | 8,682 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 10,195 | USD | 181 |
| 2005-11-28 to 2011-06-30 | 1,063,850 | USD | 2041 |
| 2010-04-01 to 2010-06-30 | 176,307 | USD | 91 |
| 2010-01-01 to 2010-06-30 | 248,328 | USD | 181 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 9,843,378 | USD | |
| At 2010-12-31 | 11,231,682 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 223,896 | USD | |
| At 2010-12-31 | 336,945 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-06-30 | 2,527,341 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 3,927,983 | USD | 181 |
| 2005-11-28 to 2011-06-30 | 12,404,635 | USD | 2041 |
| 2010-04-01 to 2010-06-30 | 794,271 | USD | 91 |
| 2010-01-01 to 2010-06-30 | 1,176,325 | USD | 181 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-06-30 | 1,392,238 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 2,028,561 | USD | 181 |
| 2005-11-28 to 2011-06-30 | 6,809,548 | USD | 2041 |
| 2010-04-01 to 2010-06-30 | 468,044 | USD | 91 |
| 2010-01-01 to 2010-06-30 | 625,428 | USD | 181 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 51,739,712 | shares | |
| At 2010-12-31 | 51,647,171 | shares |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 135,356 | USD | |
| At 2010-12-31 | 53,639 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 226,506 | USD | |
| At 2010-12-31 | 247,547 | USD |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-06-30 | 1,135,103 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 1,899,422 | USD | 181 |
| 2005-11-28 to 2011-06-30 | 5,595,087 | USD | 2041 |
| 2010-04-01 to 2010-06-30 | 326,227 | USD | 91 |
| 2010-01-01 to 2010-06-30 | 550,897 | USD | 181 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-06-30 | 62,618 | USD | 181 |
| 2005-11-28 to 2011-06-30 | 155,583 | USD | 2041 |
| 2010-01-01 to 2010-06-30 | 23,622 | USD | 181 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-06-30 | 1,157,203 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 1,279,855 | USD | 181 |
| 2005-11-28 to 2011-06-30 | -3,332,092 | USD | 2041 |
| 2010-04-01 to 2010-06-30 | -176,174 | USD | 91 |
| 2010-01-01 to 2010-06-30 | -248,108 | USD | 181 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-06-30 | -113,049 | USD | 181 |
| 2005-11-28 to 2011-06-30 | 223,896 | USD | 2041 |
| 2010-01-01 to 2010-06-30 | -28,635 | USD | 181 |
Inspect the source
- Entity
- INVIVO THERAPEUTICS HOLDINGS CORP. / CIK 0001292519
- Captured
- SEC response SHA-256
e5ef5d92c1b3dbb01ecea1d495941133d151b2802447d9492e239939c94b9e1b
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001292519.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))